Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients
Submitted by
admin
on May 1, 2010 - 11:03am
Source:
Vadvdert
News Tags:
Abbott Laboratories
Kaletra
HIV
Headline:
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients
Do Not Allow Advertisers to Use My Personal information
